Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
USE OF DISCOIDIN DOMAIN RECEPTOR 2 IN DIAGNOSIS OF GLIOMA AND RELATED COMPUTER-READABLE MEDIUM
Document Type and Number:
WIPO Patent Application WO/2024/056075
Kind Code:
A1
Abstract:
Disclosed in the present invention is the use of a reagent for detecting the expression level of discoidin domain receptor 2 (DDR2) in the preparation of a kit for diagnosing glioma in a subject, wherein the level of DDR2 in a sample from the subject is greater than that in a control who does not suffer from the disease, indicating that the subject has glioma. Further disclosed in the present invention are a kit, a method and a computer-readable medium for diagnosing glioma. In the present invention, glioma is efficiently and accurately diagnosed by means of detecting the DDR2.

Inventors:
SU JIN (CN)
Application Number:
PCT/CN2023/119117
Publication Date:
March 21, 2024
Filing Date:
September 15, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
FIBROINOVA BIOMEDICAL TECH GUANGZHOU COMPANY LTD (CN)
International Classes:
G01N33/574; A61K31/4188; A61P35/00; G01N33/573
Domestic Patent References:
WO2022040506A22022-02-24
WO2022007283A12022-01-13
WO2013034933A12013-03-14
Foreign References:
CN116027038A2023-04-28
CN116626294A2023-08-22
US20100068207A12010-03-18
US20160340738A12016-11-24
US20110287011A12011-11-24
EP3428647A12019-01-16
Attorney, Agent or Firm:
WINGUAN PATENT AND TRADEMARK ATTORNEYS (CN)
Download PDF: